Advertisement
Menopausal hormone therapy is not tied to any increase in long-term all-cause or cause-specific mortality

Hormone Therapy in Menopause Not Tied to Increased Mortality

0
Findings based on long-term follow up of both all-cause, cause-specific deaths
Does being a physician carry a moral obligation to respond to calls for medical assistance on airplanes? That is the topic of an article published in the Sept. 12 issue of the Journal of the American Medical Association.

Are Physicians Obligated to Help on Planes?

0
One administrative physician explains his sense of obligation to help
Rupture of the distal biceps tendon in a patient with heart failure with preserved ejection fraction should raise suspicion for wild-type transthyretin amyloidosis

Distal Bicep Tendon Rip Tied to Transthyretin Amyloidosis

0
Findings in patients with heart failure with preserved ejection fraction
Romosozumab treatment followed by alendronate is linked to reduced risk of fractures versus alendronate alone for postmenopausal women with osteoporosis

ASBMR: Romosozumab Reduces Fracture Rate in Osteoporosis

0
Reduced risk of new vertebral fractures, nonvertebral fractures for romosozumab and alendronate
Bacterial infections that have sickened 39 people in seven states have been linked to puppies sold through Petland

CDC: Human Campylobacter Linked to Pet Store Puppies

0
Campylobacter can spread through contact with dog feces
Neurological complications associated with anti-programmed death 1 antibody treatment have a diverse phenotype

Diverse Neurological Effects Linked to Anti-PD-1 Therapy

0
Complications seen after median of 5.5 cycles of anti-PD-1-inhibitors; include myopathy, neuropathies
Height is an independent predictor of venous thromboembolism

Greater Height Tied to Higher Risk of Venous Thromboembolism

0
Study using sibling pairs discordant for height reduces chance of familial confounding
For university students with insomnia

Online Therapy for Insomnia Linked to Improved Mental Health

0
University students undergoing online CBT program had reductions in insomnia, paranoia, hallucinations
For patients with locally advanced

Longer Progression-Free Survival for Durvalumab in NSCLC

0
Longer median progression-free survival from randomization, higher response rate with durvalumab
The median cost of cancer drug development is $648.0 million

Median Cost of Cancer Drug Development $648.0 Million

0
Total revenue from sales of 10 drugs was $67.0 billion, with total R&D spending of $7.2 billion